Pulmonary Hypertension

February 12, 2016February 18, 2016

Pulmonary Hypertension Program at Orlando Health Heart Institute Receives National Accreditation

The Pulmonary Hypertension Association (PHA)’s Accreditation Program for Pulmonary Hypertension Care Centers (PHCC) recently recognized the Orlando Health Heart Institute’s Pulmonary Hypertension Program as one of PHA’s Comprehensive Care Centers. ... Read more

February 11, 2016February 18, 2016

Sildenafil May Be Better Therapy for PAH When Combined with Ambrisentan Instead of Bosentan, Study Says

News, Pulmonary Hypertension

A new study reported that sildenafil may be better suited for patients with pulmonary arterial hypertension (PAH) when given in combination with ambrisentan instead of bosentan. The study, “Pharmacokinetic and ... Read more

February 9, 2016May 13, 2016

PHA Asks People to Support 80-Year-Old ‘Pacing Parson’ as He Walks to Fight Pulmonary Hypertension

News, Pulmonary Hypertension

Former U.S. Marine and “Pacing Parson” Don Stevenson is fighting pulmonary hypertension (PH) with awareness and fundraising as he completes a 1,000 mile walk, but he needs support from the public ... Read more

February 8, 2016February 18, 2016

Pulmonary Hypertension Association Awards $50K Grants to 3 Pediatric PAH Researchers

News, Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA), an organization that works to bring greater hope to patients with pulmonary hypertension (PH) and their families by improving care, advancing research, and fostering a sense ... Read more

February 2, 2016February 3, 2016

European Medicines Agency Gives Positive Opinion to Uptravi for Long-Term PAH Treatment

News, Pulmonary Hypertension

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has given a positive opinion to Uptravi (selexipag) for the treatment of pulmonary ... Read more

January 26, 2016January 26, 2016

New Respiratory Therapy’s Clinical Program Getting European Patent Protection

COPD, Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension

Bellerophon Therapeutics, Inc., a clinical-stage biotherapeutics company specializing in the development of drugs and devices for cardiopulmonary conditions, recently announced that the European Patent Office has issued a Notice of Intention ... Read more

January 25, 2016May 12, 2016

Upcoming American Thoracic Society Conference on Pulmonary Diseases

Asthma, COPD, Idiopathic Pulmonary Fibrosis, Lung Cancer, News, Pulmonary Hypertension

The American Thoracic Society (ATS) is inviting all those who are interested to its 2016 International Conference at the Moscone Center in San Francisco, on topics such as pulmonary, critical ... Read more

January 22, 2016January 22, 2016

British Biotech Receives £1.5M to Develop, License New PAH Treatments

News, Pulmonary Hypertension

A new Cambridge, England-based biotech company called Morphogen-IX received £1.5 million pounds — or about $2.14 million in U.S. dollars — in seed funding to develop a potential new treatment ... Read more

January 14, 2016January 14, 2016

Sensors in Lungs Control Asthma-Induced Immune Responses

Asthma, News, Pulmonary Hypertension

Targeting a rare population of cells within the lungs may inhibit the hyperactivity of lung immune responses that underlie several diseases, including asthma. The study, “Pulmonary neuroendocrine cells function as airway ... Read more

January 6, 2016January 6, 2016

Sildenafil as PAH Therapy for Children in Need of Further Study

News, Pulmonary Hypertension

A group of researchers reviewed the results from two clinical trials, STARTS-I and STARTS-II, testing the use of sildenafil as a therapy for children with pulmonary arterial hypertension (PAH), and ... Read more